Wave Life Sciences Ltd (WVE): Kapitalflussrechnung
Kennzahl in 1000 USD | TTM 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | 65.371 | 42.727 | 108.302 | 113.305 | 3.649 | 40.964 | 20.077 | 15.983 | 14.414 | 3.704 | 1.485 | 152 |
Cashflow aus operativer Geschäftstätigkeit | -184.679,289 | -187.493 | -151.026 | -19.431 | -127.781 | -88.993 | -115.982 | -188.231 | -22.862 | -83.671 | -31.872 | -12.527 |
▸ Operative Cashflow Marge | -282,51% | -438,82% | -139,45% | -17,15% | -3.501,81% | -217,25% | -577,69% | -1.177,7% | -158,61% | -2.258,94% | -2.146,26% | -8.241,45% |
Investitionsausgaben (CapEx) | 1.580,009 | 718 | 938 | 1.115 | 1.361 | 560 | 1.338 | 3.918 | 9.938 | 18.887 | 5.567 | 1.857 |
Cashflow aus Investitionstätigkeit | -124.129,988 | -718 | -938 | -1.115 | -1.255 | -560 | -1.338 | -3.918 | -9.938 | -18.896 | -8.162 | -2.909 |
Cashflow aus Finanzierungstätigkeit | 475.654,737 | 488.235 | 253.890 | 132.534 | 67.188 | 55.828 | 154.538 | 164.399 | 65.094 | 94.374 | 29.121 | 175.593 |
Freier Cashflow | -186.259,298 | -188.211 | -151.964 | -20.546 | -129.142 | -89.553 | -117.320 | -192.149 | -32.800 | -102.558 | -37.439 | -14.384 |
▸ Freie Cashflow Marge | -284,93% | -440,5% | -140,32% | -18,13% | -3.539,11% | -218,61% | -584,35% | -1.202,21% | -227,56% | -2.768,84% | -2.521,14% | -9.463,16% |
Ausgeschüttete Dividenden | - | - | - | - | - | - | - | - | - | - | -30.000 | -113.075 |
Neuausgabe und Rückkäufe von Stammaktien | - | - | - | - | 66.083 | 55.828 | 94.656 | 164.399 | 65.110 | 94.436 | 30.258 | 175.607 |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.